The role of pelvic and/or para-aortic lymphadenectomy in surgical management of apparently early carcinosarcoma of uterus

Annals of Surgical Oncology

Volumn 17, Issue 3, 2010, Pages 861-868

  Park, Jeong Yeol ^a   Kim, Dae Yeon ^a   Kim, Jong Hyeok ^a   Kim, Yong Man ^a   Kim, Young Tak ^a   Nam, Joo Hyun ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOXORUBICIN; IFOSFAMIDE; PACLITAXEL;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER INCIDENCE; CANCER INVASION; CANCER STAGING; CANCER SURGERY; CARCINOSARCOMA; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CYTOLOGY; DISEASE FREE SURVIVAL; EARLY CANCER; FEMALE; FOLLOW UP; HUMAN; INTRAOPERATIVE PERIOD; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MIXED MULLERIAN TUMOR; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PREDICTION; RETROSPECTIVE STUDY; UTERUS CARCINOMA; UTERUS SARCOMA;

ADULT; AGED; AORTA; CARCINOSARCOMA; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PELVIC NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 77149127384     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-009-0833-6     Document Type: Article

References (22)

1. S Ali M Wells 1993 Mixed Mullerian tumors of the uterine corpus: a review Int J Gynecol Cancer 3 1 1 11 10.1046/j.1525-1438.1993.03010001.x 11578316 (Pubitemid 23207590)
2. G Echt J Jepson J Steel, et al. 1990 Treatment of uterine sarcomas Cancer 66 1 35 39 10.1002/1097-0142(19900701)66:1<35::AID-CNCR2820660108>3.0. CO;2-V 1:STN:280:DyaK3c3otlyhsg%3D%3D 2354406 (Pubitemid 20197081)
3. S Pecorelli JL Benedet WT Creasman JH Shepherd 1999 FIGO staging of gynecologic cancer. 1994-1997 FIGO Committee on Gynecologic Oncology. International Federation of Gynecology and Obstetrics Int J Gynaecol Obstet 65 3 243 249 10.1016/S0020-7292(99)00070-3 1:STN:280:DyaK1MzlsFaqtQ%3D%3D 10428343 (Pubitemid 29281577)
4. FIGO. Annual report on the results of treatment in gynecologic cancer. Int J Gynecol Obstet. 2989;28:189-93.
5. JL Benedet H Bender H Jones III HY Ngan S Pecorelli 2000 FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology Int J Gynaecol Obstet 70 2 209 262 10.1016/S0020-7292(00)00300-3 1:STN:280: DC%2BD3cvpsFegtQ%3D%3D 11041682 (Pubitemid 30674231)
6. SN Nielsen KC Podratz BW Scheithauer PC O'Brien 1989 Clinicopathologic analysis of uterine malignant mixed mullerian tumors Gynecol Oncol 34 3 372 378 10.1016/0090-8258(89)90176-5 1:STN:280:DyaL1MzlslKgsQ%3D%3D 2548936 (Pubitemid 19218581)
7. A Gadducci S Cosio A Romanini AR Genazzani 2008 The management of patients with uterine sarcoma: a debated clinical challenge Crit Rev Oncol Hematol 65 2 129 142 10.1016/j.critrevonc.2007.06.011 17706430
8. A Gadducci A Romanini 2001 Adjuvant chemotherapy in early stage uterine sarcomas: an open question Eur J Gynaecol Oncol 22 5 352 357 1:STN:280:DC%2BD38%2FktVKksA%3D%3D 11766739
9. SM Temkin M Hellmann YC Lee O Abulafia 2007 Early-stage carcinosarcoma of the uterus: the significance of lymph node count Int J Gynecol Cancer 17 1 215 219 10.1111/j.1525-1438.2006.00762.x 1:STN:280:DC%2BD2s%2FpsVChug%3D%3D 17291256 (Pubitemid 46213993)
10. FJ Major JA Blessing SG Silverberg, et al. 1993 Prognostic factors in early-stage uterine sarcoma. A Gynecologic Oncology Group study Cancer 71 4(Suppl) 1702 1709 1:STN:280:DyaK3s7mtFeisg%3D%3D 8381710
11. McCluggage WG, Haller U, Kurman RJ, et al. Mixed epithelial and mesenchymal tumours. In: Tavassoli FA, Devilee P, editors. World Health Organization classification of tumour. Pahology and genetics of tumours of the breast and female genital organs. Lyon: IARC; 2003. p. 245-49.
12. TP Manolitsas GV Wain KE Williams M Freidlander NF Hacker 2001 Multimodality therapy for patients with clinical stage I and II malignant mixed Mullerian tumors of the uterus Cancer 91 8 1437 1443 10.1002/1097-0142(20010415) 91:8<1437::AID-CNCR1150>3.0.CO;2-P 1:STN:280:DC%2BD3M3mtFCktw%3D%3D 11301390 (Pubitemid 32319253)
13. SD Yamada RA Burger WR Brewster D Anton MF Kohler BJ Monk 2000 Pathologic variables and adjuvant therapy as predictors of recurrence and survival for patients with surgically evaluated carcinosarcoma of the uterus Cancer 88 12 2782 2786 10.1002/1097-0142(20000615)88:12<2782::AID-CNCR17>3.0.CO;2-K 1:STN:280:DC%2BD3czivFylsg%3D%3D 10870061 (Pubitemid 30417939)
14. Morrow CP. Leiomyosarcoma. In: Morrow CP, Curtin JP, editors. Gynecologic cancer surgery. New York: Churchill Livingstone; 1996. p. 613-16.
15. RC Boronow CP Morrow WT Creasman PJ Disaia SG Silverberg A Miller JA Blessing 1984 Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study Obstet Gynecol 63 6 825 832 1:STN:280: DyaL2c3itVKhsw%3D%3D 6728365
16. WT Creasman CP Morrow BN Bundy HD Homesley JE Graham PB Heller 1987 Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study Cancer 60 8(Suppl) 2035 2041 1:STN:280: DyaL1c%2FgtF2ltQ%3D%3D 3652025
17. JC Schink JR Lurain CB Wallemark JS Chmiel 1987 Tumor size in endometrial cancer: a prognostic factor for lymph node metastasis Obstet Gynecol 70 2 216 219 1:STN:280:DyaL2s3lvFaqtw%3D%3D 3601286
18. SG Silverberg FJ Major JA Blessing B Fetter FB Askin SY Liao, et al. 1990 Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus. A Gynecologic Oncology Group pathologic study of 203 cases Int J Gynecol Pathol 9 1 1 19 10.1097/00004347-199001000-00001 1:STN:280:DyaK3c%2FptlKmsw%3D%3D 2152890
19. ES Podczaski CA Woomert CW Stevens Jr A Manetta JE Larson RJ Zaino, et al. 1989 Management of malignant, mixed mesodermal tumors of the uterus Gynecol Oncol 32 2 240 244 10.1016/S0090-8258(89)80041-1 1:STN:280: DyaL1M%2Fpt1WnsA%3D%3D 2536000 (Pubitemid 19041970)
20. D Nemani N Mitra M Guo L Lin 2008 Assessing the effects of lymphadenectomy and radiation therapy in patients with uterine carcinosarcoma: a SEER analysis Gynecol Oncol 111 1 82 88 10.1016/j.ygyno.2008.05.016 18674808
21. P Benedetti Panici S Basile F Maneschi, et al. 2008 Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial J Natl Cancer Inst 100 23 1707 1716 10.1093/jnci/djn397 19033573
22. H Kitchener AM Swart Q Qian C Amos MK Parmar 2009 Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study Lancet 373 9658 125 136 10.1016/S0140-6736(08)61766-3 1:STN:280: DC%2BD1M%2Fmt1yrtw%3D%3D 19070889